Almac announces £16m expansion creating 180 new jobs
Almac has announced a £16m expansion of its pharmaceutical services creating 180 jobs at its new facility in England.
The Craigavon-based group, has said the investment would expand its formulation and analytical development services to meet ongoing client demand.
This follows the announcement last week of the company’s multi-million pound acquisition of Arran Chemicals in the Republic of Ireland.
The company has successfully completed negotiations to operate a significant proportion of the 70-acre Charnwood Campus in Loughborough, England.
It is described as a world-class science, technology and enterprise park and Almac’s first facility in England.
Almac will occupy the formulation development and analytical testing facilities at the site which will complement existing development offered from its Northern Ireland headquarters.
The Charnwood facilities were originally designed and built by a global pharma company as part of its in-house formulation development, clinical manufacturing and analytical testing capabilities.
Almac has begun recommissioning of the facilities with operations focusing initially on expanding both non-potent and potent solid oral dose processing.
It is anticipated that around 180 new jobs will be created over the next five years adding to Almac’s global workforce which currently stands at over 4,000.
The facility is expected to open in early 2017.
With an initial investment into the Charnwood site of £16m in process and analytical technologies, an operational start date is targeted in early 2017.
Graeme McBurney, managing director, of Almac Pharma Services said: “As we experience increased client demand for our pharmaceutical development and niche commercial manufacturing services, this latest expansion will significantly enhance Almac’s offering, increasing capacity and capability and further demonstrating our continued commitment to support our global clients in the development and manufacturing of their drug products."
Almac was founded by Sir Allen McClay, who created his original company, Galen, in 1968. He died in 2010. The company made profits of £12.6m last year and increased its turnover by 5%. Almac is one of Northern Ireland's leading exporters.
Its headquarters are in Craigavon and it now has operations in the United States, Singapore and Tokyo. Almac provides services to other pharmaceutical firms, as well as developing its own products, mainly in cancer diagnostics.